Table 2.
ALL | AMS+ | AMS− | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Before | After | P | n | Before | After | P | n | Before | After | P | |
aPTT (26–37 sec) | 37 | 31.5 ± 3.7 | 30.8 ± 3.4 | 0.091 | 23 | 30.9 ± 3.5 | 30.1 ± 3.0 | 0.100 | 14 | 32.5 ± 3.9 | 31.9 ± 3.7 | 0.489 |
PT (70–130%) | 37 | 91.7 ± 10.3 | 94.3 ± 11.2 | 0.058 | 23 | 93.3 ± 8.8 | 93.7 ± 8.5 | 0.748 | 14 | 89.1 ± 12.3 | 95.2 ± 15.1∗ | 0.029 |
Platelet count (150–380 G/L) | 37 | 226.0 ± 43.6 | 232.3 ± 61.4 | 0.340 | 23 | 233.5 ± 36.7 | 232.3 ± 64.1 | 0.908 | 14 | 213.8 ± 52.2 | 232.4 ± 58.9∗ | 0.000 |
Fibrinogen (210–400 mg/dL) | 37 | 233.1 ± 36.9 | 238.6 ± 41.0 | 0.169 | 23 | 238.5 ± 38.8 | 246.2 ± 45.3 | 0.104 | 14 | 224.1 ± 33.0 | 226.2 ± 30.3 | 0.787 |
SpO2 (92–98%) | 37 | 98.1 ± 1.2 | 85.1 ± 6.2 | 0.000∗ | 23 | 98.4 ± 1.0 | 85.3 ± 6.9 | 0.000 | 14 | 97.5 ± 1.5 | 84.1 ± 6.2 | 0.000 |
Heart rate (72–77 bpm) | 37 | 76 ± 12 | 84 ± 15 | 0.008∗ | 23 | 79.8 ± 14.3 | 86.3 ± 16.4 | 0.011 | 14 | 72.6 ± 7.0 | 81.1 ± 12.0 | 0.042 |
aPTT, PT, platelet count, and plasma fibrinogen concentration for all participants (ALL) and for volunteers with (AMS+) and without (AMS−) AMS before and after hypoxia. Data are shown as mean values ± standard deviation.
∗for P < 0.05 as compared to pre exposure. Reference values are given in parentheses.